קונקיון אם.אם. 10 מגמל ישראל - עברית - Ministry of Health

קונקיון אם.אם. 10 מגמל

tzamal bio-pharma ltd - phytomenadione - תמיסה - phytomenadione 10 mg / 1 ml - phytomenadione - phytomenadione - for the treatment and the prophylaxis of hemorrhage.

קונקיון אם. אם. לילדים 2 מג0.2 מל ישראל - עברית - Ministry of Health

קונקיון אם. אם. לילדים 2 מג0.2 מל

tzamal bio-pharma ltd - phytomenadione - תמיסה להזרקה - phytomenadione 10 mg/ml - phytomenadione - phytomenadione - prophylaxis and treatment of haemorrhoagic disease of the newborn.

ברינאווס 20 מגמל ישראל - עברית - Ministry of Health

ברינאווס 20 מגמל

tzamal bio-pharma ltd - vernakalant hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - vernakalant hydrochloride 20 mg/ml - vernakalant - vernakalant - rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults who are hemodynamically stable.- for non-surgery patients: atrial fibrillation ? 7 days duration- for post-cardiac surgery patients: atrial fibrillation ? 3 days duration

אטקנד  4 מג ישראל - עברית - Ministry of Health

אטקנד 4 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 4 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אטקנד   8 מג ישראל - עברית - Ministry of Health

אטקנד 8 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אטקנד  16 מג ישראל - עברית - Ministry of Health

אטקנד 16 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אטקנד פלוס ישראל - עברית - Ministry of Health

אטקנד פלוס

tzamal bio-pharma ltd - candesartan cilexetil; hydrochlorothiazide - טבליה - candesartan cilexetil 16 mg; hydrochlorothiazide 12.5 mg - candesartan and diuretics - candesartan and diuretics - essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorothiazide is not sufficient.

פוסטימון 75 IU ישראל - עברית - Ministry of Health

פוסטימון 75 iu

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 75 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

פוסטימון 150 IU ישראל - עברית - Ministry of Health

פוסטימון 150 iu

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 150 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

פורטיקל ישראל - עברית - Ministry of Health

פורטיקל

tzamal bio-pharma ltd - calcitonin salmon 200 iu/dose - nasal spray - calcitonin (salmon synthetic) - fortical® nasal spray is indicated for:postmenopausal osteoporosis – fortical® calcitonin-salmon (rdna origin) nasal spray isindicated for the treatment of postmenopausal osteoporosis in women greater than 5 yearspostmenopause with low bone mass relative to healthy premenopausal women. use of fortical®calcitonin-salmon (rdna origin) nasal spray is recommended in conjunction with an adequatecalcium (at least 1000 mg elemental calcium per day) and vitamin d (400 international units perday) intake to retard the progressive loss of bone mass. the evidence of efficacy for calcitoninsalmonis based on increases in spinal bone mineral density (bmd) observed in clinical trials